Kfar-Sava, Israel Clinical Trials

A listing of Kfar-Sava, Israel clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 723 clinical trials
Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)

This is a Phase III, randomized, parallel-arm, placebo controlled, double blind, multicenter study assessing the efficacy and safety of durvalumab versus placebo following SoC chemotherapy in patients with completely resected stage II-III NSCLC who are MRD+ post surgery

durvalumab
lung carcinoma
cancer chemotherapy
Research Site
 (6.6 away) Contact site
  • 102 views
  • 02 Jun, 2021
  • +241 other locations
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low Hormone Receptor Positive Metastatic Breast Cancer

This study will evaluate the efficacy, safety and tolerability of trastuzumab deruxtecan compared with investigator's choice chemotherapy in human epidermal growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine therapy in the metastatic setting.

Research Site
 (6.6 away) Contact site
  • 35 views
  • 24 May, 2021
  • +245 other locations
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension

Selexipag is available for the treatment of pulmonary arterial hypertension (PAH) in adults in various countries. The efficacy of selexipag to delay disease progression was shown in a previous pivotal study conducted in 1156 adult patients with PAH. Given the similarities in the functional changes of PAH in children and …

selexipag
hypertension
right heart catheterization
endothelin receptor antagonist
heart disease
SCHNEIDER CHILD MED CTR INST PEDIATRIC CARD (Petach Tikvah)
 (6.6 away) Contact site
  • 34 views
  • 26 Apr, 2021
  • +92 other locations
Study to Evaluate the Safety of the EndoArt for Treatment of Subjects Suffering From Corneal Edema

Prospective, feasibility study to evaluate the safety of the EndoArt for treatment of 20 subjects suffering from corneal edema. Followed up for 12 months.

Tel Aviv Souraski Medical Center
 (9.7 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +8 other locations
A Safety Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

A randomized withdrawal study in which responders to open-label treatment with tofacitinib will be randomized in a 1:1 ratio to tofacitinib or placebo in a double-blind phase. In the double-blind phase "time to sJIA flare" will be evaluated as primary endpoint and subjects will be discontinued once they experience sJIA …

Meir Medical Center- Pharmacy
 (0.7 away) Contact site
  • 134 views
  • 16 Jun, 2021
  • +92 other locations
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations

The purpose of this study is to evaluate efficacy of erdafitinib versus chemotherapy or pembrolizumab in participants with advanced urothelial cancer harboring selected fibroblast growth factor receptor (FGFR) aberrations who have progressed after 1 or 2 prior treatments, at least 1 of which includes an anti-programmed death ligand 1(PD-[L]1) agent …

transitional cell carcinoma
pembrolizumab
renal function
carcinoma
growth factor
Rabin Medical Center, Beilinson Hospital
 (6.6 away) Contact site
  • 271 views
  • 03 Jun, 2021
  • +587 other locations
Study of Evobrutinib in Participants With RMS (evolutionRMS 1)

The study is to evaluate the efficacy and safety of evobrutinib administered orally twice daily versus Teriflunomide (Aubagio), administered orally once daily in participants with Relapsing Multiple Sclerosis (RMS).

teriflunomide
evobrutinib
aubagio
Research Site 307
 (6.6 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +246 other locations
Fixed-Dose Trial in Early Parkinson's Disease (TemPo-1)

The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics (PK) of 2 fixed doses of tavapadon and placebo in participants with early Parkinson's Disease.

essential tremor
parkinsonism
mao-b inhibitor
early parkinson's
bradykinesia
Rabin Medical Center
 (6.6 away) Contact site
  • 0 views
  • 12 May, 2021
  • +73 other locations
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168)

Primary Objective: To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio) measured by annualized adjudicated relapse rate (ARR) in participants with relapsing forms of MS Secondary Objective: To assess efficacy of SAR442168 compared to teriflunomide (Aubagio) on disability progression, MRI lesions, cognitive performance …

contraceptive use
hmr1726
aubagio
teriflunomide
pregnancy test urine
Investigational Site Number 3760001
 (9.8 away) Contact site
  • 10 views
  • 17 Jun, 2021
  • +121 other locations
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Phase III, double-blind, randomised study assessing the efficacy of capivasertib + fulvestrant vs placebo + fulvestrant for the treatment of patients with locally advanced (inoperable) or metastatic HR+/HER2- breast cancer following recurrence or progression on or after AI therapy.

Research Site
 (0.8 away) Contact site
  • 50 views
  • 02 Jun, 2021
  • +222 other locations